THYROCARENSEThyrocare Technologies LimitedMediumNeutral
Announced Mon, 25 Aug · 20:51 IST

Thyrocare Technologies Limited has informed the Exchange regarding Notice of Postal Ballot

Board & Shareholder Meetings View source PDF

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Thyrocare Technologies has issued a Postal Ballot notice seeking shareholder approval for the appointment of Mr. Alok Kumar Jagnani (DIN: 00644360) as a Non-Executive & Non-Independent Director. Mr. Jagnani was previously the Chief Financial Officer (CFO) of Thyrocare since August 2023 and stepped down from that role on July 23, 2025, to take up the position of Group CFO at API Holdings Limited, the ultimate holding company of Thyrocare. He is a Chartered Accountant with over 20 years of experience in finance, risk management, internal controls, and ERP systems. The e-voting window runs from August 28, 2025 to September 26, 2025, with results to be declared on or before September 29, 2025. He will not receive any separate remuneration as a director but remains eligible for ESOPs under the Thyrocare ESOP Scheme and holds 2,443 equity shares in the company.

Likely market impact

This is a routine internal leadership transition with no material change for minority shareholders — Mr. Jagnani is moving from executive (CFO) to non-executive board role and continues with the promoter group (API Holdings). Approval is through postal ballot and is widely expected to pass, so no significant stock price impact is anticipated.